1.l-5-11CGlutamine PET imaging noninvasively tracks dynamic responses of glutaminolysis in non-alcoholic steatohepatitis.
Yiding ZHANG ; Lin XIE ; Masayuki FUJINAGA ; Yusuke KURIHARA ; Masanao OGAWA ; Katsushi KUMATA ; Wakana MORI ; Tomomi KOKUFUTA ; Nobuki NENGAKI ; Hidekatsu WAKIZAKA ; Rui LUO ; Feng WANG ; Kuan HU ; Ming-Rong ZHANG
Acta Pharmaceutica Sinica B 2025;15(2):681-691
Inhibiting glutamine metabolism has been proposed as a potential treatment strategy for improving non-alcoholic steatohepatitis (NASH). However, effective methods for assessing dynamic metabolic responses during interventions targeting glutaminolysis have not yet emerged. Here, we developed a positron emission tomography (PET) imaging platform using l-[5-11C]glutamine ([11C]Gln) and evaluated its efficacy in NASH mice undergoing metabolic therapy with bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES), a glutaminase 1 (GLS1) inhibitor that intervenes in the first and rate-limiting step of glutaminolysis. PET imaging with [11C]Gln effectively delineated the pharmacokinetics of l-glutamine, capturing its temporal-spatial pattern of action within the body. Furthermore, [11C]Gln PET imaging revealed a significant increase in hepatic uptake in methionine and choline deficient (MCD)-fed NASH mice, whereas systemic therapeutic interventions with BPTES reduced the hepatic avidity of [11C]Gln in MCD-fed mice. This reduction in [11C]Gln uptake correlated with a decrease in GLS1 burden and improvements in liver damage, indicating the efficacy of BPTES in mitigating NASH-related metabolic abnormalities. These results suggest that [11C]Gln PET imaging can serve as a noninvasive diagnostic platform for whole-body, real-time tracking of responses of glutaminolysis to GLS1 manipulation in NASH, and it may be a valuable tool for the clinical management of patients with NASH undergoing glutaminolysis-based metabolic therapy.
2.Ventral Schwannoma of the Thoracolumbar Spine.
Hitoshi YAMAHATA ; Satoshi YAMAGUCHI ; Masanao MORI ; Fumikatsu KUBO ; Hiroshi TOKIMURA ; Kazunori ARITA
Asian Spine Journal 2013;7(4):339-344
We report two patients with ventral schwannoma in the thoracolumbar region manifesting as low back pain with or without paraparesis. In both patients magnetic resonance imaging (MRI) revealed a heterogeneously-enhanced intradural extramedullary mass in the thoracolumbar region. The tumors were successfully removed via the posterior approach. Their histology was consistent with schwannoma. Postoperative MRI showed no evidence of a tumor in either patient. Spinal schwannomas are common benign intradural extramedullary spinal neoplasms; most arise from the dorsal- and very few from the anterior roots. A literature review revealed that ventral schwannomas, including giant tumors as in the one from case 2 in our study, affect mainly the cervical region, and most are surgically addressed via the posterior approach. Careful handling of the spinal cord is mandatory for satisfactory surgical results.
Humans
;
Low Back Pain
;
Magnetic Resonance Imaging
;
Neurilemmoma*
;
Paraparesis
;
Spinal Cord
;
Spinal Neoplasms
;
Spine*

Result Analysis
Print
Save
E-mail